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Genotype-phenotype mapping is hampered by
countless genomic changes between species. We
introduce a computational ‘‘forward genomics’’
strategy that—given only an independently lost
phenotype and whole genomes—matches genomic
and phenotypic loss patterns to associate specific
genomic regions with this phenotype. We conducted
genome-wide screens for two metabolic pheno-
types. First, our approach correctly matches the in-
activated Gulo gene exactly with the species that
lost the ability to synthesize vitamin C. Second, we
attribute naturally low biliary phospholipid levels in
guinea pigs and horses to the inactivated phospho-
lipid transporter Abcb4. Human ABCB4 mutations
also result in low phospholipid levels but lead
to severe liver disease, suggesting compensatory
mechanisms in guinea pig and horse. Our simulation
studies, counts of independent changes in existing
phenotype surveys, and the forthcoming availability
of many new genomes all suggest that forward geno-
mics can be applied to many phenotypes, including
those relevant for human evolution and disease.
INTRODUCTION
Despite a wealth of information obtained by comparative geno-
mics (Green et al., 2010; McLean et al., 2011; Pollard et al.,
2006; Prabhakar et al., 2006; Zhu et al., 2007), it remains
extremely difficult to link any of the millions of genomic changes
with the many interesting and important phenotypic differ-
ences found between even closely related species (Cheng
et al., 2005; Varki and Altheide, 2005). To overcome this diffi-
culty, we devise a method that takes advantage of parallel
evolution of phenotypic traits across a larger phylogeny. Due
to purifying selection, extant species that preserve an ancestralCtrait should also conserve the ancestral genes—or, more
generally, genomic regions—underlying this trait (Figure 1A).
In contrast, in species that lose this trait, nonpleiotropic
genomic regions necessary only for the lost trait should switch
to evolve neutrally following the phenotypic loss. If sufficient
evolutionary time has passed since trait loss, relaxed selection
will erode these DNA sequences in trait-loss lineages, resulting
in elevated divergence from the ancestral sequence or even
complete loss. If trait loss happens in independent lineages,
these regions should specifically diverge in exactly those line-
ages over time, regardless of whether the initial inactivating
mutations leading to trait loss are identical in the independent
lineages (Figure 1, and exemplified below). Thus, independent
trait loss should give a unique evolutionary sequence diver-
gence signature that violates the expected evolutionary pattern
multiple times.
Together with approaches such as genome-wide association
studies (GWAS), our strategy is conceptually similar to forward
genetics, where one starts with a given phenotype and seeks
the underlying mutation. We call this family of approaches
‘‘forward genomics.’’ With two examples and simulation studies,
we show that—given a specific, independently lost phenotype—
a cross-species genomic screen for genes and genomic regions
with this specific signature can highlight functional components
of the genetic information for this trait.
RESULTS AND DISCUSSION
Measuring Sequence Divergence
To measure sequence divergence, we first reconstruct the most
likely DNA sequence of the boreoeutherian ancestor (Figure 2C)
separately for each mammalian conserved (coding or noncod-
ing) region, with an estimated 98% accuracy (Blanchette et al.,
2004). Then, we compute the percent of identical bases pre-
served by each extant species, while taking great care to distin-
guish assembly gaps (missing data) and low-quality sequences
from real mutations. For coding genes, we combine DNA se-
quence divergence of all coding exons. We then screen for
genes or individual regions where all trait-loss species haveell Reports 2, 817–823, October 25, 2012 ª2012 The Authors 817
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progression in time Figure 1. Evolutionary Model and Assump-
tions behind Our Forward Genomics
Approach
(A) An ancestral trait is passed to descendant
species, along with the genomic regions re-
quired for this trait, which evolve under purifying
selection.
(B) One lineage loses the ancestral trait due to an
inactivating mutation in a trait-required region.
(C) Following trait loss, all trait-specific (non-
pleiotropic) regions switch to evolve neutrally and
begin to accumulate random mutations in the
first trait-loss lineage. Meanwhile, two additional
independent lineages lose this trait, due to inde-
pendent mutations occurring either in the same or
in other trait-required regions.
(D) All trait-specific regions continue to erode independently in the three different trait-loss lineages, whereas their counterparts in the trait-preserving species
are conserved due to purifying selection. This characteristic evolutionary signature can be detected with forward genomics, revealing functional components of
this (monogenic or polygenic) trait.diverged more from the ancestral sequence (lower percent of
identical bases) than all trait-preserving species.
Gulo Loss Perfectly Matches the Loss of Vitamin C
Synthesis
The ability to synthesize the essential nutrient L-ascorbic acid
(vitamin C) is an ancestral trait that arose in vertebrates. Using
a biochemical assay, it has been found that—unlike most
mammals—guinea pigs, certain primates including humans,
and multiple bat species have lost the ability to synthesize
vitamin C (Linster and Van Schaftingen, 2007). These nonsynthe-
sizing species require a dietary source of vitamin C to prevent
scurvy, a disease in which defective collagen prevents the for-
mation of strong connective tissue. Mapping the presence/
absence of this phenotype to the phylogenetic tree of sequenced
mammals (termed ‘‘phenotree’’ hereafter) shows that this trait
was lost at least four times independently (Figure 2C).
We asked whether forward genomics can discover the
underlying cause for loss of vitamin C synthesis, given only
this phenotree and a whole genome alignment of species for
which vitamin C-synthesizing ability was biochemically mea-
sured (Extended Experimental Procedures available online).
This genomic screen finds gulonolactone (L-) oxidase (Gulo)
as the only gene that perfectly matches our phenotree with
substantially more divergence in all nonsynthesizers (Figure 2).
The detection of Gulo is extremely robust to details of our
forward genomics screen. Gulo is repeatedly singled out
when screening individual exons instead of genes, even when
doing a genome-wide screen of 544,549 individual conserved
coding and noncoding regions, when reconstructing to dif-
ferent ancestors, and also when measuring divergence after
correcting for the different evolutionary rates of different species
(Figure S1).
Gulo encodes a key enzyme responsible for vitamin C
synthesis. A targeted Gulo knockout in mouse abolishes the
ability to synthesize vitamin C (Maeda et al., 2000). Inactivating
mutations in the Gulo gene have been identified in several
nonsynthesizing species (Cui et al., 2011b; Nishikimi et al.,
1992, 1994; Ohta and Nishikimi, 1999). We find Gulo inactiva-
tion in additional species (Figure S2) and show that Gulo is818 Cell Reports 2, 817–823, October 25, 2012 ª2012 The Authorsinactivated in all and only the sequenced nonsynthesizers.
Other sequenced mammals not measured for their ability to
synthesize vitamin C (kangaroo rat, pika, alpaca, dolphin, and
hedgehog) all lack Gulo-inactivating mutations, suggesting trait
retention. Although Gulo is a clear candidate gene for this
trait, forward genomics can detect it based on the vitamin C
phenotree and genome alignments alone. Gulo also exemplifies
that forward genomics does not require that the initial inactivat-
ing mutations leading to trait loss are identical in different line-
ages (Figure 1), as no single exon exhibits an inactivating
mutation in all four nonsynthesizing lineages (Figure S2A), sug-
gesting independent gene inactivation at different genomic
regions.
Abcb4 Loss Perfectly Matches Low Biliary Phospholipid
Levels
We next tested whether our forward genomics approach can
be applied to continuous traits that vary in magnitude between
species. The composition of bile has been studied in many
animals due to its relevance in digestion, cholesterol metabo-
lism, and gall stone formation. The levels of biliary phospho-
lipids, which protect against bile-acid-induced cell damage
(Puglielli et al., 1994), vary in mammals (Figure 3A). Whereas
most measured mammals have levels well above 1 mM, in-
cluding humans at 2.8 mM, biliary phospholipid levels are
particularly low in guinea pig (0.11 mM) and horse (0.38 mM)
(Coleman et al., 1979; Engelking et al., 1989). We converted
the continuous trait into a presence/absence trait by postu-
lating that a subset of species with the lowest phospholipid
levels may share a common associated genomic loss signa-
ture. Screening only the 11 genomes of species with measured
phospholipid levels (Extended Experimental Procedures), there
are 796 genes that are most diverged in guinea pig alone
(our lowest value): a list too long to analyze. However, when
grouping guinea pig and horse (next-lowest phospholipid
level), only eight genes are more diverged in these two indepen-
dent lineages (Figures 3A and 3B). Of these eight genes, only
Abcb4 has a bile-related function (Figure 3C). Abcb4 is also
the strongest candidate gene when screening at the exon level
(Figure S3).
Figure 2. A Forward Genomics Screen to Match an Ancestral Presence/Absence Trait Pinpoints Gulo Inactivation in Vitamin C-Non-
synthesizing Species
(A) For every gene (dot) in the mouse genome (x axis), we measured how well it matches the given phenotree by counting the number of species (y axis) whose
divergence level violates the expectation of divergence or conservation based on the vitamin C phenotree shown in (C). Gulo, with 0 violations, is the only gene
that perfectly matches.
(B) Elevated ratio of nonsynonymous to synonymous (Ka/Ks) substitutions shows that remaining megabat and guinea pig exons evolve under relaxed pressure to
preserve the Gulo protein sequence.
(C) Nonsynthesizing species show elevated sequence divergence in the Gulo coding sequence, with a divergence margin (gray) that perfectly separates them
from synthesizing species. Note that the microbat and megabat lineage have independently lost this trait, as intermediate bat species (without a sequenced
genome) were biochemically shown to synthesize vitamin C (Cui et al., 2011a).
(D) Graphical sequence alignment of the Gulo coding region. Rows match species in (C). Large deletions (red blocks) occurred only in nonsynthesizing species.
See also Figures S1 and S2.Abcb4 encodes the multidrug resistance 3 P-glycoprotein,
a transporter that is crucial for phospholipid secretion into
bile. Interestingly, ABCB4 mutations in humans lead to biliary
phospholipid levels similar to those in guinea pigs (0.05–
0.13 mM), resulting in gall stone formation and bile canaliculi
damage that can often only be treated by liver transplantation
(Davit-Spraul et al., 2010). Targeted Abcb4 knockout mice have
undetectable biliary phospholipid levels (Smit et al., 1993) and
are used as models for the human disease state. Our screen is
the first to discover numerous Abcb4 gene-inactivating muta-
tions, as well as relaxed selection on the defunct Abcb4 protein
sequence in naturally occurring species (Figure 3; Table S1).
The discovery that two well-studied mammals have naturally in-
activatedAbcb4but avoiddeleterious effects suggests that other
genomic changes in guinea pigs and horses presumably com-
pensate for deleterious consequences of Abcb4 loss. Whereas
horse bile is not well characterized, guinea pig bile differs fromCthe bile of other rodents by being very dilute and highly concen-
trated in the less hydrophobic ursodeoxycholic acid (Hofmann
et al., 2010). Further studies into nature’s own compensatory
mechanisms may lead to new therapeutic targets and strategies
for ameliorating the consequences of Abcb4 mutations in
humans.
Simulating Trait Loss Suggests Broad Forward
Genomics Applicability
To further test whether neutral evolution following independent
trait loss results in an evolutionary signature that can be
detected by our forward genomics approach, we simulated
the independent loss of the vitamin C and biliary phospholipid
traits. We used the real mammalian phylogeny and computa-
tionally evolved a short ancestral genome containing 103,088
coding and noncoding regions. Following the assumptions in
Figure 1, we simulated trait loss by evolving the 11 (27) exonsell Reports 2, 817–823, October 25, 2012 ª2012 The Authors 819
Figure 3. Forward Genomics Implicates Independent Inactivation of the Human Disease Gene ABCB4 in Two Species with Low Levels of
Biliary Phospholipids
(A) The level of biliary phospholipids is a continuous trait that varies over 200-fold betweenmammals. Seven hundred and ninety-six genes showmore divergence
in guinea pig than ten othermeasured species, but only eight genes show elevated divergence in both guinea pig and horse, the two species with the lowest biliary
phospholipid levels.
(B) We plot (y axis) the number of violations of each gene (dot) in the mouse genome (x axis) against the biliary phospholipid level phenotree in (E). The eight genes
with 0 violations are labeled.
(C) Of the eight genes, only Abcb4 (bold) has a bile-related function.
(D) Increased Abcb4 nonsynonymous to synonymous (Ka/Ks) substitution ratios for guinea pig and horse.
(E and F) Divergence from the reconstructed common ancestor (E) and a graphical sequence alignment representation (F) of the Abcb4 coding sequence reveal
elevated divergence and deletions (red blocks) in trait-loss species only.
See also Figure S3 and Table S1.of Gulo (Abcb4) neutrally in the independent trait-loss species,
while evolving other regions under purifying selection. We then
tested whether forward genomics can find some of the 11 (27)
exons of Gulo (Abcb4) among the >100,000 other regions,
based only on their specific divergence signature. We found
that nearly all simulation runs detect Gulo/Abcb4 exons, and
that these genes most often are the only/strongest hit (Figures
4A–4C). The simulated data offer support that the specific820 Cell Reports 2, 817–823, October 25, 2012 ª2012 The Authorsevolutionary signature of independent trait loss can be used to
identify the genes for both traits by highlighting some of their
exons.
We further used the simulation framework to test other trait-
loss scenarios. We found that performance depends on the
evolutionary time since trait loss, the evolutionary rate of change
of individual species, the number of independent trait losses, and
the strength of purifying selection in trait-preserving species
A B
D
C
Figure 4. Broad Applicability of Our Forward Genomics Approach
(A) We show the branches in the phylogeny that evolve neutrally for the trait-associated gene in the trait-loss simulation (red: vitamin C synthesis; green: biliary
phospholipids). For biliary phospholipids, we simulated a loss that happened either 0.05 or 0.1 substitutions per site ago.
(B) Simulations suggest that the evolutionary signature of independent loss of vitamin C synthesis can highlight exons of the trait-associated gene in nine of ten
iterations (iteration 5 gave no hit). We observed no false positives.
(C) Simulations of the biliary phospholipid trait show that in at least seven of ten iterations, the single top-ranked hit is an exon of the trait-associated gene (shown
as *), and that the trait-associated gene often has themost hits (shown as #), whereas false positives are scattered across the genome. The chart (right) shows that
true positives (green) usually rank highly.
(D) In three very different vertebrate phenotype-scoring studies, an average of 42% of phenotypes have changes in two or more independent lineages, the
conditions required for forward genomics analysis.
See also Figure S4.(Figures S4A–S4D). Importantly, despite these dependencies,
forward genomics can detect some genetic trait components
for a wide range of plausible trait-loss scenarios, with the excep-
tion of very recent losses.
Many Phenotypes Are Changed in Independent
Lineages
Our forward genomics approach is constrained by the existence
and accessibility of independently lost traits. Fortunately, the
scientific community has been scoring traits since the days
of Linnaeus (Linnaeus, 1758), with patterns of trait evolution
collected into large databases such as MorphoBank (http://
www.morphobank.org). We analyzed three vertebrate pheno-
type sets (selected for availability of a corresponding molecular
phylogeny and for addressing distinct vertebrate clades), mea-
suring 207, 166, and 88 different traits in 20 species of bats,
primates, and anglerfish, respectively. By mapping traits to the
phylogeny, we find that 40% of scored traits show changes
in independent lineages, consistent across all three sets (Fig-
ure 4D). In all cases, the sampled species make only a fraction
of their clade. As expected, independently changed traits
should increase as more and more species are sampled (Fig-
ure S4E). Few of the species sampled in these phenotype sets
are currently sequenced, but many of them are targeted for
genome sequencing by the Genome10K project (HausslerCet al., 2009). As these and additional genomes become available,
hundreds of phenotypes can be subjected to our approach.
By requiring a longer evolutionary timescale and focusing
on between-species differences, our method complements
approaches, such as GWAS, to map phenotypic differences
between individuals of a population. The biliary phospholipid
example suggests potential applicability to continuous traits by
testing different thresholds, to traits with changes in only two
independent lineages, and to traits where phenotypic informa-
tion is available for only a few of the sequenced species. Our
forward genomics approach relies only on ancestral DNA se-
quence information loss and can therefore detect both coding
and noncoding regions (Figure S4). Pleiotropic regions neces-
sary for both the lost and unrelated traits may only experience
a relaxation of selective pressure, making it harder to detect
them. However, although the degree of pleiotropy in our genome
is still not completely known, recent work provides evidence that
many genes and quantitative trait loci (QTLs) affect only a very
small number of traits (Wagner and Zhang, 2011), and regulatory
noncoding regions are thought to be less pleiotropic than the
genes they regulate (Carroll, 2008). Also, future screens could
improve on detecting the more subtle signatures of relaxed
selection. Although forward genomics may not be successful
for all trait losses, the availability of thousands of vertebrate
and arthropod genomes in the coming years (Haussler et al.,ell Reports 2, 817–823, October 25, 2012 ª2012 The Authors 821
2009; Robinson et al., 2011) suggests applicability to many
additional traits. Leveraging the unique signature of indepen-
dently evolved phenotypic patterns can help to tie the study
of nature’s tremendous phenotypic diversity to its underlying
genomic basis. To this end, we provide a web portal at http://
phenotree.stanford.edu/ to allow users to run any phenotree
search against our data. The portal provides a visualization
and download of the results and links to the University of Califor-
nia, Santa Cruz (UCSC) genome browser. Finally, it is not
straightforward to distinguish real mutations from genomic arti-
facts. Most current gene family collections focus only on collect-
ing intact members by mapping gene structures across species.
When mapping fails, no call is made to distinguish between true
gene loss and an unresolved state due to low quality or missing
sequence data. A systematic search for genes lost in wild-type
species will likely suggest new organisms useful for studying
the phenotypic consequences of human disease mutations.
EXPERIMENTAL PROCEDURES
Alignments and Input Data
We extended themouse (mm9 assembly) 30-way genome alignment provided
by the UCSC genome browser (Dreszer et al., 2012) by 13 species, using the
UCSC pipeline of lastz, chaining, netting, and multiz (Extended Experimental
Procedures). The alignment is available through our portal. To obtain con-
served regions, we downloaded PhastCons (Siepel et al., 2005) most con-
served elements from the UCSC genome browser. Elements within 30 bp of
each other were merged. We retained only elements R70 bp after merging.
Exons of ‘‘known genes’’ were downloaded from the UCSC genome browser.
Wealways excluded themitochondrial, random, andhaplotype chromosomes.
Ancestral Sequence Reconstruction and Percent Identity Values
Given themultiple alignment of a conserved regionwith conservation in at least
one outgroup species (elephant, rock hyrax, tenrec, armadillo, sloth, opossum,
platypus, chicken, zebra finch, or lizard), we used prequel (Siepel et al., 2005)
(parameters --no-probs --keep-gaps) to reconstruct the ancestral sequences.
We define the percent of identical bases in the pairwise alignment between
ancestor and extant species as id/(id + subs + ins + del) * 100, where id, subs,
ins, and del are the numbers of identical bases, substitutions, inserted bases,
and deleted bases, respectively. We ignore low-quality base positions (>1%
error rate). We consider the following large-scale events: (1) Large lineage-
specific insertions were counted as inserted bases. (2) Parts of the conserved
region that are unalignable between ancestor and extant species (defined as
being so diverged that no sequence alignment can be computed; unalignable
regions are annotated in the multiple alignment) were added to the number of
substitutions. Specifically, we add the number of ancestral bases correspond-
ing to this unalignable region if the unalignable part is at the end, or we add the
maximum of the number of ancestral bases and the number of extant bases in
this region if the unalignable part is flanked by aligning blocks on both sides.
Unalignable regions that map to an assembly gap in this species were ignored.
If the entire conserved region is unalignable or deleted, the percent identity (%
id) is set to 0. (3) If the aligning sequence is not colinear in the extant species
(different strands or different chromosomes/scaffolds), we do not compute
a %id value for this species because these cases frequently arise due to
incomplete genome assemblies or assembly artifacts. Percent identity ranges
from 0 (complete loss) to 100 (identity to the ancestor). For gene-based
screens, we computed a %id value for the entire coding region of a gene by
summing the number of matches for each coding exon and dividing that
number by the summed alignment lengths.
Screening for Conserved Regions that Evolve Faster in Species
Lacking a Trait
We searched for regions/genes where the %id values in all trait-loss species
are at least 1% lower than in all trait-preserving species. We ignored species822 Cell Reports 2, 817–823, October 25, 2012 ª2012 The Authorswith missing data (no %id value). We excluded regions that had missing
data for many species. To get a quantitative measurement of how well a
region/gene matches the phenotree, we computed the minimal number of
‘‘violating’’ trait-loss or trait-preserving species whose %id values have to
be removed to get a 1%separation. Themaximum number of violating species
is the number of trait-loss species for both vitamin C and biliary phospholipids,
as there are more trait-preserving than trait-loss species.
Bioinformatics Analysis of the Gulo Locus and Resequencing
Standard bioinformatics analysis of the Gulo gene and its genomic locus as
well as standard PCR-based resequencing are described in the Extended
Experimental Procedures.
Simulating Independent Trait Loss
To evolve a given ancestral genome, we used Evolver (http://www.drive5.com/
evolver/) with standard parameters (Extended Experimental Procedures) and
the real mammalian phylogeny. To simulate independent trait loss, we
randomly picked a small number of functional regions and assumed that
they encode trait-specific information (true positives). All other regions are
false positives. We evolved these regions neutrally for a fixed terminal part
of the branch leading to a trait-loss lineage.
We restricted the ancestral genome simulation to human chromosome 1
with its 1,603 RefSeq genes (downloaded from UCSC) as this already
consumed 50,000 CPU hours and 1.6 TB of disk space. We considered all
coding exons and functional noncoding regionsR70 bp that have an average
accept probability of%0.7 (i.e., we ignore regions under very weak selection),
giving a total of 103,088 regions. The selected trait-specific regions (%27 in all
tests) comprise only 0.026% of all regions. Evolver outputs the pairwise align-
ment of the evolved and ancestral genome, which we used to measure%id for
all functional regions. As above, we used our approach to find regions where all
trait-loss species areR1% more diverged than all trait-preserving species.
To simulate the loss of vitamin C synthesis, we picked a gene with 11 coding
exons (like Gulo; 11 true positives). True positives evolved neutrally for the
branches in the human-tarsier subtree, the final 0.07 substitutions per site of
the guinea pig branch, the microbat (M. lucifugus) branch, and the final
0.045 substitutions per site of the megabat (P. vampyrus) branch (Extended
Experimental Procedures). To simulate the biliary phospholipid trait, we picked
a gene with 27 coding exons (like Abcb4) and simulated two scenarios: trait
loss 0.05 and 0.1 substitutions per site ago.
ACCESSION NUMBERS
The GenBank accession numbers for the Gulo resequencing data are
JX259503–JX259509.
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